Recent News

• 05.07.2025 - PolyPid to Participate in The Citizens Life Sciences Conference
• 05.07.2025 - PolyPid to Participate in The Citizens Life Sciences Conference
• 04.22.2025 - PolyPid to Participate in The Citizens Life Sciences Conference
• 04.22.2025 - PolyPid to Participate in The Citizens Life Sciences Conference
• 03.17.2025 - March 17, 2025 5:00 PM EDT - Mar 18, 2025 : PolyPid to Participate in the 37th Annual ROTH Conference
• 03.17.2025 - March 17, 2025 5:00 PM EDT - Mar 18, 2025 : PolyPid to Participate in the 37th Annual ROTH Conference
• 03.11.2025 - PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
• 03.11.2025 - PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
• 03.03.2025 - PolyPid to Participate in the 37th Annual ROTH Conference
• 03.03.2025 - PolyPid to Participate in the 37th Annual ROTH Conference

Recent Filings

• 04.03.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 03.11.2025 - EX-99.1 EX-99.1
• 03.11.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 02.26.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors